SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

PIRAMAL PHARMA

BSE: 543635 01 Oct 2025
Healthcare
₹ 199.3
PIRAMAL PHARMA LIMITED specializes in Pharmaceuticals within the Healthcare sector.

PIRAMAL PHARMA - Share Price & Details

Market Cap
₹24,954
High /Low
308.0 / 180.0
Stock P/E
289.0
Book Value
₹61.3
Dividend Yield
0.07
ROCE
6.45
ROE
₹1.11
Face Value
10.0
PEG Ratio
-7.48
EVEBITDA
₹18.4
Debt
4,856
CMP / FCF
1,133
Debt to equity
₹0.6
NP Ann
91.1
High price all time
308.0
Piotroski score
₹7.0
Graham Number
32.0
No. Eq. Shares
133.0
Net CF
₹-36.9
Net profit
98.1
Price to book value
3.06
Interest Coverage
₹1.9
Low price all time
61.6
Industry PE
33.0
Reserves
₹6,801
Free Cash Flow
₹233

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
29 Jul 2025 ICICI Securities Buy ₹205.65 ₹265 34.4% moneycontrol View
29 Jul 2025 Motilal Oswal Buy ₹205.65 ₹240 21.8% moneycontrol View
29 May 2025 Motilal Oswal Buy ₹205.75 ₹250 21.2% moneycontrol View
15 May 2025 Motilal Oswal Buy ₹208.55 ₹250 21.7% moneycontrol View
24 Oct 2024 Motilal Oswal Buy ₹256.4 ₹310 14.7% moneycontrol View
25 Sep 2024 Motilal Oswal Buy ₹226.45 ₹260 -3.7% moneycontrol View
28 Jul 2024 ICICI Securities Buy ₹166.5 ₹200 -25.5% moneycontrol View
13 May 2024 ICICI Securities Buy ₹154.35 ₹190 -29.2% moneycontrol View
13 May 2024 Motilal Oswal Buy ₹154.35 ₹190 -29.2% moneycontrol View
13 May 2024 Asit C. Mehta Buy ₹154.35 ₹180 -32.9% moneycontrol View
01 Apr 2024 Asit C. Mehta Buy ₹129.85 ₹171 -36.3% moneycontrol View
01 Feb 2024 ICICI Securities Buy ₹138.3 ₹180 -32.9% moneycontrol View
31 Jan 2024 Motilal Oswal Buy ₹144.2 ₹165 -38.5% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
PIRAMAL PHARMA LIMITED11508.01131.49698.80.8524,954289.0
Syngene International Limited8159.0740.07993.01.832455748.4
PFIZER LTD.6702.21917.56030.541.9122558147.0

Peer Comparison Chart


About PIRAMAL PHARMA

PIRAMAL PHARMA LIMITED, with Security Code 543635, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Piramal Pharma - Kaynes Tech, Eternal among 8 F&O stocks that saw a high increase in futures open interest

(22 Sep 2025)
OI: 1,54,52500| Chg OI: 24,65000 | Chg OI (%): 18.98 Piramal Pharma.
Read more →

Piramal Pharma Solutions boosts formulation development at Morpeth site with Korsch XM-12

(19 Sep 2025)
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd.,...
Read more →

From Compliance to Commitment: How Piramal Pharma is Reimagining Sustainability in Pharma

(18 Sep 2025)
In its fourth annual Sustainability Report, Piramal Pharma charts an evolution from foundational ESG reporting to embedding sustainability...
Read more →

Divi’s, Piramal Pharma to Sai Life: Jefferies lists four pharma stocks to buy for up to 30% gains. Do you own any?

(15 Sep 2025)
India's CRDMO sector is set for growth in the next 3-5 years, with Jefferies highlighting four stocks including Divi's Labs, Sai Life are...
Read more →

A Look At The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

(10 Sep 2025)
Key Insights Piramal Pharma's estimated fair value is ₹173 based on 2 Stage Free Cash Flow to Equity With ₹198 share...
Read more →

Piramal Pharma jumps 8%; JM Financial says 'Buy' stock, shares target price

(02 Sep 2025)
The Piramal Pharma stock rose 8 per cent to hit a high of Rs 201.45 apiece on BSE, trimming its 2025 losses to 22.7per cent.
Read more →